Identiv Business Summary

Identiv, Inc. (INVE) is a pure-play Internet of Things (IoT) solutions provider that generates revenue primarily through the design and sale of specialized Radio-Frequency Identification (RFID), Near Field Communication (NFC), and Bluetooth Low Energy (BLE) transponders, smart labels, and readers. Following the $145 million divestiture of its physical security business to Vitaprotech in late 2024, the company transitioned to a high-margin business model focused on regulated and complex environments, including healthcare, life sciences, luxury goods, and smart packaging. Its primary revenue streams are derived from value-added hardware sales and integrated IoT solutions, such as pharmaceutical cold-chain tracking and digital product passports for EU compliance. Identiv competes directly with industry leaders such as Impinj, Avery Dennison (Smartrac), and HID Global, positioning itself as a specialized engineering partner for mission-critical, high-precision applications rather than a mass-market commodity hardware manufacturer. The leadership team is led by CEO Kirsten Newquist, who joined in 2024 after a 17-year career at Avery Dennison, where she served as Global VP of Smartrac and Medical divisions. Key executives include CFO Ed Kirnbauer, appointed in August 2025, and Chief Strategy Officer Manfred Mueller, a 25-year company veteran who has overseen Identiv’s technological evolution since its early stages. While the company’s corporate lineage traces back to the 1990 founding of SCM Microsystems and the 2009 merger forming Identive Group, the current board reflects a high-pedigree shift toward medical and enterprise technology; it is chaired by James Ousley (former CEO of Savvis) and includes directors such as Dr. Richard Kuntz (former Chief Medical Officer of Medtronic) and Mick Lopez (former CFO of Ribbon Communications and executive at Cisco and IBM). Institutional investors, including major mutual funds, maintain a significant stake in the company as it executes its 'Perform-Accelerate-Transform' strategy.